Why Choose us

Speed & Quality

Divergene excels in crafting a powerful framework that expedites the creation, testing, and deployment of cutting-edge NGS analysis workflows. Our approach seamlessly integrates a blend of proprietary and tailor-made tools for optimal results.

Experienced Team

Our dedicated team comprises Ph.D. bioinformaticians, offering specialized knowledge in vector discovery, engineering, and vector quality control. We leverage our expertise to craft top-tier, custom NGS solutions to meet your unique needs.

Competitive Pricing

We employ a subscription-based Software as a Service (SaaS) model to provide NGS analysis pipelines as a service, simplifying your process and eliminating the need for intricate software and the development of an in-house team.

NGS Platform Agnostic

Divergene’s exceptional blend of profound expertise in cell and gene therapy, genome editing, and sequencing empowers robust iterative design for platform-agnostic tools.

Democratizing data-driven cell and gene therapy, together.

At Divergene, our mission revolves around shaping the future of AI-assisted cell and gene therapy, and genome editing. We’re dedicated to integrating multimodal data, breaking down existing data silos, and crafting advanced machine learning models. These efforts aim to provide actionable insights, ultimately empowering gene therapy professionals to enhance patient outcomes.

Retain ownership of your data

Divergene’s platform offers a secure and readily accessible environment for the standardization, computation, and analysis of NGS data. This empowers the extraction of valuable insights from intricate sequencing datasets, with the potential to advance gene therapy and editing. We provide organizations with swift and comprehensive data analysis capabilities, enabling them to perform sequencing on their own samples, retain ownership of their samples and data, and leverage Divergene’s platform to derive actionable insights.

Our mission is to establish a pioneering technology company that significantly enhances patient outcomes through advanced NGS data analysis.

Our vision

At Divergene, we recognize that the convergence of molecular biology, data science, and computer science is the epicenter of groundbreaking advancements. Our paramount goal is to facilitate breakthrough therapies and elevate human well-being. We are actively dedicated to developing the requisite technologies to bring this vision to fruition.

Within the fabric of Divergene, we’ve cultivated a robust entrepreneurial ethos, igniting a passion within every team member to drive meaningful change. Our corporate DNA, built upon the pillars of quality, precision, and resilience, is the cornerstone of our success and a beacon of hope for millions, promising a brighter future.

Our Services

Divergene collaborates closely with CROs, CDMOs, cell and gene therapy companies to enhance their next-generation sequencing capabilities, spanning from upstream vector engineering to downstream vector quality control, including genome heterogeneity and integrity analysis. Our focus is on tailoring best-in-class NGS analysis workflows that precisely align with their specific requirements.

End-to-end Sequencing

End-to-end Sequencing

From nucleotide preparations to interactive dashboard reporting, Divergene offers comprehensive services. We manage library preparation, QC, sequencing, and analysis, utilizing Illumina, PacBio, or Nanopore sequencing platforms tailored to your specific requirements.

NGS Analysis Development

Our clients conduct NGS testing on their samples utilizing their in-house sequencing platforms. Divergene steps in to meticulously process and analyze the raw NGS data files, culminating in the creation of interactive and actionable dashboards and reports.

WHO WE ARE

Facts about Divergene
99 %
Positive feedback from customers and partners
< 60 days
To build, test and deploy new NGS analysis pipeline
> 8 x
More affordable than hiring an in-house team
> 10 x
Better customer service and response rate

Our Team

Kam To, PhD, MBA, MS
General Manager
Paola Correa, PhD
Technology Leader
Alexander Ross, MBA
Chief Operating and Finance Officer
Jennifer Campbell
Vice President, Strategic Marketing and Sales Operations

Get in touch

WE ARE ACCEPTING NEW CHALLENGES!

Enhance your NGS data 10X with Divergene’s powerful bioinformatics platform, and scale your genomic projects. We would be happy to answer your questions or discuss your projects.

Scam Alert: We are aware there are impersonators pretending to be Divergene’s HR. We don’t reach out to candidates by text or perform interviews by text/phone.



Contact

800 Park Offices Dr, Morrisville, NC 27560
support@divergene.com